Portal de Periódicos da CAPES

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis

2015; Wiley; Volume: 2; Issue: 3 Linguagem: Inglês

10.1002/acn3.164

2328-9503

Melania Spadaro, Lisa Ann Gerdes, Marie Cathrin Mayer, Birgit Ertl‐Wagner, Sarah Laurent, Markus Krumbholz, Constanze Breithaupt, Tobias Högen, Andreas Straube, Armin Giese, Reinhard Hohlfeld, Hans Lassmann, Edgar Meinl, Tania Kümpfel,

Systemic Lupus Erythematosus Research

We present histological, MRI, and clinical features of an adult patient with relapsing encephalomyelitis and antibodies against myelin oligodendrocyte glycoprotein (MOG). Furthermore, we report molecular details of the recognized epitope that is specific for human MOG. A brain biopsy revealed multiple sclerosis (MS)-type II pathology. Some features overlapped with both MS and neuromyelitis optica spectrum disorders (NMOSD), whereas others were distinct from both MS and NMOSD. Immunoadsorption and rituximab induced clinical stabilization. This case contributes a new, so far missing link in the emerging spectrum of MOG-antibody-associated encephalomyelitis.